These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6917884)

  • 1. How the FDA determines the "safety" of drugs: are drugs used in obstetrics really safe?
    Haire D
    J Nurse Midwifery; 1982; 27(2):28-32. PubMed ID: 6917884
    [No Abstract]   [Full Text] [Related]  

  • 2. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game.
    Begley S; Hager M; Wilson L
    Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942
    [No Abstract]   [Full Text] [Related]  

  • 3. Unapproved uses of approved drugs: The physician, the package insert, and the FDA.
    Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165
    [No Abstract]   [Full Text] [Related]  

  • 4. ACOG Committee Opinion. Number 283, May 2003. New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy.
    ACOG Committee Opinion. American College of Obstetrician and Gynecologist
    Obstet Gynecol; 2003 May; 101(5 Pt 1):1049-50. PubMed ID: 12738178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
    Brucker MC; King TL
    J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kelsey's Commandos: FDA investigates the investigators.
    Small WE
    Am Pharm; 1979 Jun; 19(6):30-3. PubMed ID: 463736
    [No Abstract]   [Full Text] [Related]  

  • 7. Children, drugs, and the Food and Drug Administration: studies of pediatric drugs are beginning to catch up.
    Ward RM
    Pediatr Ann; 2001 Apr; 30(4):189-94. PubMed ID: 11303433
    [No Abstract]   [Full Text] [Related]  

  • 8. How does the FDA affect you and your practice?
    Novitch M
    Leg Aspects Med Pract; 1979 Mar; 7(3):23-6. PubMed ID: 423685
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs and biologics in pregnancy and breastfeeding: FDA in the 21st century.
    Kweder SL
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):605-9. PubMed ID: 18704917
    [No Abstract]   [Full Text] [Related]  

  • 10. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 11. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA rejects extra-label drug use proposal.
    J Am Vet Med Assoc; 1983 Nov; 183(9):929. PubMed ID: 12002580
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy labeling.
    FDA Drug Bull; 1979 Sep; 9(4):23-4. PubMed ID: 488582
    [No Abstract]   [Full Text] [Related]  

  • 14. The process of drug decision making: perspectives of an FDA Commissioner.
    Hayes AH
    Hosp Formul; 1985 Aug; 20(8):896-900. PubMed ID: 10272396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosurgical devices and drugs.
    Burton CV
    Neurosurgery; 1979 Jan; 4(1):97-8. PubMed ID: 450224
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory concerns at various phases of drug development.
    Aurecchia S; Orloff D; Sobel S
    Am J Cardiol; 1998 Apr; 81(8A):2F-4F. PubMed ID: 9604895
    [No Abstract]   [Full Text] [Related]  

  • 17. Critics fear the FDA is going too far in cutting industry's regulatory load.
    Demkovich LE
    Natl J (Wash); 1982 Jul; 14(29):1249-52. PubMed ID: 10255878
    [No Abstract]   [Full Text] [Related]  

  • 18. Sounding board. Creative tension: FDA and medicine.
    Kennedy D
    N Engl J Med; 1978 Apr; 298(15):846-50. PubMed ID: 345121
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of the course of pregnancy and labor in women following parlodel treatment of sterility].
    Ovsiannikova TV; Pshenichnikova TIa; Osenin AA; Speranskaia NV
    Akush Ginekol (Mosk); 1987 Apr; (4):32-5. PubMed ID: 3605522
    [No Abstract]   [Full Text] [Related]  

  • 20. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.